 |
|
|
| |
High Early Virological Response with Telaprevir-PegIFN-RBV in treatment-experienced, HCV genotype 1, HIV coinfected patients: ANRS HC26 TelapreVIH Study
|
| |
| |
Reported by Jules Levin
CROI 2013 March 3-6 Atlanta
Cotte L, Braun J, Lascoux-Combe C,
Vincent C, Pol S, Valantin MA, Lacombe K,
Neau D, Aboulker JP, Molina JM
on behalf of the ANRS HC26 study group
|
| |
|
|
|
|
|
